ApeX Therapeutics, a cancer-focused drug discovery and development company with technology licensed from Indiana University Research and Technology Corporation, has received a Phase I, Small Business Innovation Research grant for $240,332 from the National Cancer Institute at the National Institutes of Health to develop an oral or injectable form of medicine to more effectively treat… Read more »